PharmacyCodes



Oxaloplatine [French] en es it fr

Categoria

Oxaloplatine [French] Nombres de marca, Oxaloplatine [French] Analogos

Oxaloplatine [French] Marca los nombres de mezcla

  • No information avaliable

    • Oxaloplatine [French] Formula quimica

    C8H12N2O4Pt

    Oxaloplatine [French] RX enlace

    http://www.rxlist.com/cgi/generic/eloxatin.htm

    Oxaloplatine [French] FDA hoja

    Oxaloplatine_[French] FDA

    Oxaloplatine [French] MSDS (hoja de seguridad de materiales)

    Oxaloplatine_[French] MSDS

    Oxaloplatine [French] Sintesis de referencia

    No hay información disponible

    Oxaloplatine [French] Peso molecular

    395.27 g/mol

    Oxaloplatine [French] Punto de fusion

    No information avaliable

    Oxaloplatine [French] H2O Solubilidad

    No hay información disponible

    Oxaloplatine [French] Estado

    Solid

    Oxaloplatine [French] LogP

    No information avaliable

    Oxaloplatine [French] Formas de dosificacion

    No hay información disponible

    Oxaloplatine [French] Indicacion

    Para el tratamiento de neoplasias malignas de colon, recto y ovario

    Oxaloplatine [French] Farmacologia

    Oxaliplatino inhibe selectivamente la síntesis del ácido desoxirribonucleico (ADN). El contenido de guanina y citosina se correlaciona con el grado de oxaliplatino inducida por entrecruzamiento. En altas concentraciones de la droga, el ARN celular y la síntesis de proteínas también se suprimen.

    Oxaloplatine [French] Absorcion

    No hay información disponible

    Oxaloplatine [French] Toxicidad

    No hay información disponible

    Oxaloplatine [French] Informacion de Pacientes

    Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.

    Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.

    Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.

    Oxaloplatine [French] Organismos afectados

    Humanos y otros mamíferos